AI in medical imaging: A hot topic at ECR 2024
Date: 16/02/2024
At European Congress of Radiology (ECR) meeting scheduled to be held on February 28-March 3, 2024 in Vienna, the leading medical-electronics companies such as Royal Philips and GE HealthCare are actively participating.
Royal Philips is set to showcase its latest AI-enabled innovations aimed at enhancing patient care at the European Congress of Radiology (ECR) annual meeting in Vienna to be held on Feb 28 - March 03 . Leveraging artificial intelligence, these cutting-edge technologies are designed to empower healthcare professionals with more accurate diagnoses, streamlined workflows, and improved patient outcomes, emphasizing Philips' commitment to patient-centric care.
The theme of 'Next Generation Radiology' underscores the focus on innovation at ECR 2024. Philips, along with other health tech leaders, will highlight significant advancements in speed and precision enabled by AI, aimed at improving patient care outcomes.
On February 28, Elie Chaillot, President and CEO GE HealthCare International to join an ESR session alongside Prof. Carlo Catalano, to delve into GE HealthCare’s care pathways approach and the company’s dedication to precision care. In addition to this enlightening session, three clinical symposia will be valuable forums, offering in-depth perspectives from industry leaders, featuring renowned experts:
On Neurology on February 28, exploring Neuroimaging in the New Era of Amyloid Targeted Therapies
On Oncology on February 29 addressing the escalating significance of imaging in the era of advanced cancer therapies.
On Cardiology on March 1, providing insights into Multimodality Cardiac Imaging from Diagnosis to Therapy Planning.
Elie Chaillot said: “We are excited about the continuation of our collaboration with the European Society of Radiology for the latest edition of ECR. Our innovations aim to bring healthcare to the next level by creating insights for better, more targeted, and more individualized patient care. The collaboration between industry, academia, healthcare professionals and patient groups is critical in this journey to improve patient outcomes and drive the future of healthcare.”
Another medical imaging expert Guerbet to unveil significant advances in Diagnostic Imaging with the approval in Europe of Elucirem (Gadopiclenol) the next generation of GBCA from Guerbet and a disruptive Artificial Intelligence program.
A paper titled “Developing, Purchasing, Implementing and Monitoring AI Tools in Radiology: Practical Considerations” was published by five leading radiology societies the American College of Radiology (ACR), Canadian Association of Radiologists (CAR), European Society of Radiology (ESR), Royal Australian and New Zealand College of Radiologists (RANZCR), and Radiological Society of North America (RSNA) via the ESR’s online gold open access journal Insights into Imaging.
Image Source: Royal Philips
